These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8739775)

  • 1. Molecular biology of heart disease. Synopsis of the pathophysiological basis of cardiac hypertrophy, familial hypertrophic cardiomyopathy, long QT syndrome and Marfan syndrome.
    Kurabayashi M; Yazaki Y
    Intern Med; 1996 Apr; 35(4):243-8. PubMed ID: 8739775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular genetics of cardiovascular diseases].
    Schunkert H; Hense HW
    Dtsch Med Wochenschr; 1995 Apr; 120(15):533-9. PubMed ID: 7720536
    [No Abstract]   [Full Text] [Related]  

  • 3. The phenotype/genotype relation and the current status of genetic screening in hypertrophic cardiomyopathy, Marfan syndrome, and the long QT syndrome.
    Burn J; Camm J; Davies MJ; Peltonen L; Schwartz PJ; Watkins H
    Heart; 1997 Aug; 78(2):110-6. PubMed ID: 9326982
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases:hypertrophic cardiomyopathy, long-QT syndrome, and Marfan syndrome. A statement for healthcare professionals from the Councils on Clinical Cardiology, Cardiovascular Disease in the Young, and Basic Science, American Heart Association.
    Maron BJ; Moller JH; Seidman CE; Vincent GM; Dietz HC; Moss AJ; Sondheimer HM; Pyeritz RE; McGee G; Epstein AE
    Circulation; 1998 Oct; 98(14):1460-71. PubMed ID: 9841131
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of DNA testing for diagnosis, management, and genetic screening in long QT syndrome, hypertrophic cardiomyopathy, and Marfan syndrome.
    Vincent GM
    Heart; 2001 Jul; 86(1):12-4. PubMed ID: 11410552
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic testing for risk stratification in hypertrophic cardiomyopathy and long QT syndrome: fact or fiction?
    Ackerman MJ
    Curr Opin Cardiol; 2005 May; 20(3):175-81. PubMed ID: 15861004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genetics of hereditary cardiopathies].
    Debrus S; de Meeus A; Jean MK; Bouvagnet P
    Arch Mal Coeur Vaiss; 1996 May; 89(5):619-27. PubMed ID: 8758572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of molecular genetics in cardiac diseases.
    Schwartz K
    Herz; 1994 Apr; 19(2):69-74. PubMed ID: 8194834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of molecular genetics on clinical cardiology.
    Mayosi BM; Watkins H
    J R Coll Physicians Lond; 1999; 33(2):124-31. PubMed ID: 10340258
    [No Abstract]   [Full Text] [Related]  

  • 10. AHA assesses the impact of genotyping on diagnosis of genetic cardiac disease. American Heart Association.
    Morey SS
    Am Fam Physician; 1999 May; 59(10):2915-6, 2918. PubMed ID: 10348078
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetics of cardiovascular disease.
    Cymet T
    Compr Ther; 2010; 36():18-9. PubMed ID: 21229815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic aspects of the etiology of arrhythmia].
    Thierfelder L
    Z Kardiol; 2000; 89 Suppl 3():1-5. PubMed ID: 10810779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertrophic cardiomyopathy, long QT interval and coronary perforator disease in the Noonan syndrome.
    de Gregorio C; Recupero A
    J Cardiovasc Med (Hagerstown); 2020 Feb; 21(2):161-163. PubMed ID: 31592851
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiac Alterations in Patients with Familial Lipodystrophy.
    Romano MMD; Chacon PAI; Ramalho FNZ; Foss MC; Schmidt A
    Arq Bras Cardiol; 2020 Feb; 114(2):305-312. PubMed ID: 32215503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic angiotensin II stimulation in the heart produces an acquired long QT syndrome associated with IK1 potassium current downregulation.
    Domenighetti AA; Boixel C; Cefai D; Abriel H; Pedrazzini T
    J Mol Cell Cardiol; 2007 Jan; 42(1):63-70. PubMed ID: 17070838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New molecular genetic tests in the diagnosis of heart disease.
    Lebo MS; Baxter SM
    Clin Lab Med; 2014 Mar; 34(1):137-56, vii-viii. PubMed ID: 24507793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular aspects of cardiac hypertrophy and their implications in cardiomyopathies].
    Kimura A
    Nihon Rinsho; 2000 Jan; 58(1):223-7. PubMed ID: 10885318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ICD for primary prevention in patients with inherited cardiac diseases: indications, use, and outcome: a comparison with secondary prevention.
    Olde Nordkamp LR; Wilde AA; Tijssen JG; Knops RE; van Dessel PF; de Groot JR
    Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):91-100. PubMed ID: 23275262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetics and molecular biology of cardiac hypertrophy].
    Rossi G; Cecchi F
    G Ital Cardiol; 1995 Dec; 25(12):1643-8. PubMed ID: 8707013
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical conditions associated with abnormal QT interval: clinical implications].
    Crotti L; Dossena C; Mastantuono E; Dagradi F; Schwartz PJ
    G Ital Cardiol (Rome); 2013 Jan; 14(1):55-65. PubMed ID: 23258205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.